慢性肝病且肺动脉压正常患者的右心腔形态与功能改变
连续纳入51例无肺动脉高压及其他心血管疾病的慢性肝病患者与25例年龄性别匹配对照,用标准超声心动图测量右心室与右心房尺寸、右心室收缩/舒张功能指标及心肌应变。两组右心室和右心房尺寸及常规功能与应变指标均无显著差异(P > .05),仅右心室游离壁厚度在病例组显著增高(4.15 ± 0.64 vs 3.75 ± 0.37 mm;P < .001);作者认为这可能是肝硬化心肌病所致,但在无肺动脉高压时未引起右心室收缩或舒张功能受损。
要点
- 慢性肝病且肺动脉压正常者右心室游离壁厚度较对照增高(4.15 ± 0.64 vs 3.75 ± 0.37 mm;P < .001)。
- 两组右心室与右心房尺寸、常规右心室收缩/舒张功能指标及应变成像均无显著差异(P > .05)。
- 服用β受体阻滞剂者右心室游离壁平均应变较未服用者显著减低(-20.37 ± 6.6 vs -24.07 ± 6.52;P = .04)。
核心结论
- 慢性肝病患者在肺动脉收缩压正常时右心室游离壁厚度增高,推测继发于肝硬化心肌病;但在无肺动脉高压情况下,肝硬化心肌病未导致右心室收缩或舒张功能受损。
研究设计与样本
- 研究论文;连续纳入51例已知慢性肝病但无肺动脉高压或其他心血管疾病的患者,以及25例年龄和性别匹配的参与者;按终末期肝病模型评分和Child-Pugh分级对慢性肝病患者进行分类;采用标准超声心动图方法测量。
关键影像表现/征象
- 研究组与对照组的右心室舒张末期、收缩末期及右心房尺寸相似。
- 常规右心室收缩/舒张功能指标及应变成像结果在两组间均无差异(P > .05)。
- 仅右心室游离壁厚度在研究组显著增高(均值 ± 标准差,4.15 ± 0.64 对 3.75 ± 0.37 mm;P < .001)。
诊断标准与关键数值
- 慢性肝病患者中右心室舒张末期内径与右心室游离壁厚度显著相关(P = .018;r = 0.334)。
- 慢性肝病患者中右心房面积与右心室游离壁厚度显著相关(P = .017;r = 0.335)。
- 服用β受体阻滞剂者右心室游离壁平均应变较未服用者显著减低(-20.37 ± 6.6 对 -24.07 ± 6.52;P = .04)。
临床应用与阅片要点
- 在肺动脉压正常的慢性肝病患者中评估右心时,右心室游离壁厚度增高可能是可观察到的形态学改变。
- 原文结论指出,在无肺动脉高压时肝硬化心肌病未导致右心室收缩或舒张功能受损。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the effects of chronic liver disease (CLD) on the structural and functional characteristics of right-sided heart chambers in patients with normal pulmonary artery pressure.
METHODS: Fifty-one patients with known CLD but without pulmonary hypertension or other cardiovascular conditions were consecutively enrolled, along with 25 age- and sex-matched participants. Patients with CLD were classified according to the Model of End-Stage Liver Disease score and Child-Pugh classification. Right ventricular (RV) and right atrial (RA) dimensions, indices of RV systolic/diastolic function, and myocardial strain were measured by standard echocardiographic methods.
RESULTS: Patients in the study group had similar RV end-diastolic, end-systolic, and RA dimensions compared to controls. Similarly, neither the conventional indices of RV systolic/diastolic function nor the strain imaging findings were different between groups (P > .05). Only RV free wall thickness was significantly higher in the study group (mean ± SD, 4.15 ± 0.64 versus 3.75 ± 0.37 mm; P < .001). Right ventricular end-diastolic diameter (P = .018; r = 0.334) and RA area (P = .017; r = 0.335) had a significant correlation with RV free wall thickness in patients with CLD. Patients treated with beta blockers were found to have a significant reduction in mean RV free wall strain compared to patients who did not receive beta blocker treatment (-20.37 ± 6.6 versus -24.07 ± 6.52; P = .04).
CONCLUSIONS: Patients with CLD had increased RV free wall thickness despite normal systolic pulmonary pressure, presumably secondary to cirrhotic cardiomyopathy. In the absence of pulmonary hypertension, however, cirrhotic cardiomyopathy did not cause impaired RV systolic or diastolic function.
引用
- Günay N, Erdem Ş, Güvenç TS, et al. Morphologic and Functional Changes in Right-Sided Cardiac Chambers in Patients With Chronic Liver Disease and Normal Pulmonary Artery Pressure. J Ultrasound Med. 2017. PMID: 29266366. doi:10.1002/jum.14516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。